FDA.reportPublic FDA data

sodium phenylbutyrate 3.67 GM Granules for Oral Suspension

RxCUI
2626380
RxNorm name
sodium phenylbutyrate 3.67 GM Granules for Oral Suspension
Display name
sodium phenylbutyrate 3.67 GM Granules for Oral Suspension
Full name
sodium phenylbutyrate 3.67 GM Granules for Oral Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
89abc31c-43e8-4809-9eb7-172cb31a86f1sodium phenylbutyrate 3.67 GM Granules for Oral Suspension [PSN] · sodium phenylbutyrate 3670 MG Granules for Oral Suspension [SCD] · sodium phenylbutyrate 3.67 GM Granules for Oral Suspension [SY]34These highlights do not include all the information needed to use OLPRUVA TM safely and effectively. See full prescribing information for OLPRUVA. OLPRUVA (sodium phenylbutyrate) for oral suspension Initial U.S. Approval: 199620241218